CureVac (CVAC)
(Delayed Data from NSDQ)
$2.33 USD
+0.02 (0.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $2.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for CureVac NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -262.51 | -462.91 | -148.33 | NA |
Depreciation/Amortization & Depletion | NA | 25.01 | 17.59 | 12.19 | NA |
Net Change from Assets/Liabilities | NA | -132.29 | 26.91 | 697.00 | NA |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | NA | 68.27 | -404.32 | 35.88 | NA |
Net Cash From Operating Activities | NA | -301.52 | -822.72 | 596.74 | NA |
Property & Equipment | NA | -92.74 | -139.40 | -41.50 | NA |
Acquisition/ Disposition of Subsidiaries | NA | -0.29 | 0.00 | 0.00 | NA |
Investments | NA | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | NA | -5.48 | -4.13 | -10.22 | NA |
Net Cash from Investing Activities | NA | -98.51 | -143.53 | -51.72 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 71.01 | 418.75 | 991.19 | NA |
Issuance (Repayment) of Debt | NA | 0.00 | -28.06 | -51.28 | NA |
Increase (Decrease) Short-Term Debt | NA | -4.45 | -3.57 | -3.42 | NA |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Financing Activities | NA | 66.56 | 387.12 | 936.50 | NA |
Effect of Exchange Rate Changes | NA | 0.88 | 5.54 | -5.77 | NA |
Net Change In Cash & Equivalents | NA | -332.59 | -573.59 | 1,475.75 | NA |
Cash at Beginning of Period | NA | 854.96 | 1,484.21 | 35.05 | NA |
Cash at End of Period | NA | 522.37 | 910.62 | 1,510.80 | NA |
Diluted Net EPS | NA | -1.39 | -2.48 | -1.12 | NA |
Fiscal Year End for CureVac NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | -188.82 | -136.09 | -61.63 |
Depreciation/Amortization & Depletion | NA | NA | 18.94 | 12.53 | 6.28 |
Net Change from Assets/Liabilities | NA | NA | -81.22 | -64.78 | -52.67 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | NA | 6.99 | 9.84 | 1.13 |
Net Cash From Operating Activities | NA | NA | -244.11 | -178.50 | -106.90 |
Property & Equipment | NA | NA | -41.56 | -29.68 | -13.98 |
Acquisition/ Disposition of Subsidiaries | NA | NA | 0.00 | 0.00 | 0.00 |
Investments | NA | NA | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | NA | -2.84 | -0.16 | -0.14 |
Net Cash from Investing Activities | NA | NA | -44.40 | -29.84 | -14.13 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | 257.15 | 257.38 | 253.29 |
Issuance (Repayment) of Debt | NA | NA | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | NA | -4.32 | -2.75 | -1.35 |
Payment of Dividends & Other Distributions | NA | NA | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | NA | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | NA | 252.84 | 254.62 | 251.94 |
Effect of Exchange Rate Changes | NA | NA | 1.22 | -0.34 | -0.26 |
Net Change In Cash & Equivalents | NA | NA | -34.45 | 45.94 | 130.66 |
Cash at Beginning of Period | NA | NA | 539.63 | 540.62 | 532.19 |
Cash at End of Period | NA | NA | 505.18 | 586.55 | 662.84 |
Diluted Net EPS | NA | NA | -0.24 | -0.33 | -0.29 |